﻿{"id":29329,"date":"2025-11-10T16:09:21","date_gmt":"2025-11-10T09:09:21","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=29329"},"modified":"2025-11-10T16:09:21","modified_gmt":"2025-11-10T09:09:21","slug":"serine","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/serine\/","title":{"rendered":"Serine"},"content":{"rendered":"<p>(Ph. Eur. monograph 0788)<\/p>\n<p>C<sub>3<\/sub>H<sub>7<\/sub>NO<sub>3<\/sub>\u00a0 \u00a0 \u00a0 \u00a0 105.1\u00a0 \u00a0 \u00a0 \u00a0 \u00a056-45-1<\/p>\n<p><strong>Action and use<\/strong><\/p>\n<p>Amino acid.<\/p>\n<h2>DEFINITION<\/h2>\n<p>(2S)-2-Amino-3-hydroxypropanoic acid.<\/p>\n<p>Product of fermentation or of protein hydrolysis.<\/p>\n<h3>Content<\/h3>\n<p>98.5 per cent to 101.0 per cent (dried substance).<\/p>\n<h2>CHARACTERS<\/h2>\n<h3>Appearance<\/h3>\n<p>White or almost white, crystalline powder or colourless crystals.<\/p>\n<h3>Solubility<\/h3>\n<p>Freely soluble in water, practically insoluble in ethanol (96 per cent).<\/p>\n<h2>IDENTIFICATION<\/h2>\n<p>First identification: A, B.<\/p>\n<p>Second identification: A, C, D.<\/p>\n<p>A. Specific optical rotation (see Tests).<\/p>\n<p>B. Infrared absorption spectrophotometry (2.2.24).<\/p>\n<p>Comparison: serine CRS.<\/p>\n<p>C. Thin-layer chromatography (2.2.27).<\/p>\n<p>Test solution: Dissolve 10 mg of the substance to be examined in a 1 per cent V\/V solution of hydrochloric acid R and dilute to 50 mL with the same solution.<\/p>\n<p>Reference solution: Dissolve 10 mg of serine CRS in a 1 per cent V\/V solution of hydrochloric acid R and dilute to 50 mL with the same solution.<\/p>\n<p>Plate: TLC silica gel plate R.<\/p>\n<p>Mobile phase: glacial acetic acid R, water R, butanol R (20:20:60 V\/V\/V).<\/p>\n<p>Application: 5 \u03bcL.<\/p>\n<p>Development: Over 2\/3 of the plate.<\/p>\n<p>Drying: In air.<\/p>\n<p>Detection: Spray with ninhydrin solution R and heat at 105 \u00b0C for 15 min.<\/p>\n<p>Results: The principal spot in the chromatogram obtained with the test solution is similar in position, colour and size to the principal spot in the chromatogram obtained with the reference solution.<\/p>\n<p>D. To 1 mL of a 10 g\/L solution of the substance to be examined in a test tube, add 5 mL of a 20 g\/L solution of sodium periodate R. Heat on a water-bath and collect the vapour on glass wool moistened with water R and inserted in the opening of the test tube. After heating for 5 min, transfer the glass wool to a test tube containing 1 mL of a 15 g\/L solution of chromotropic acid, sodium salt R and 3 mL of sulfuric acid R. Heat on a water-bath for 10 min. A violet-red colour is produced.<\/p>\n<h2>TESTS<\/h2>\n<h3>Solution S<\/h3>\n<p>Dissolve 2.5 g in distilled water R and dilute to 50 mL with the same solvent.<\/p>\n<h3>Appearance of solution<\/h3>\n<p>Solution S is clear (2.2.1) and not more intensely coloured than reference solution BY<sub>6<\/sub> (2.2.2, Method II).<\/p>\n<h4>Specific optical rotation (2.2.7)<\/h4>\n<p>+ 14.0 to + 16.0 (dried substance).<\/p>\n<p>Dissolve 2.50 g in dilute hydrochloric acid R and dilute to 25.0 mL with the same acid.<\/p>\n<h3>Ninhydrin-positive substances<\/h3>\n<p>Amino acid analysis (2.2.56). For analysis, use Method 1.<\/p>\n<p>The concentrations of the test solution and the reference solutions may be adapted according to the sensitivity of the equipment used. The concentrations of all solutions are adjusted so that the system suitability requirements described in general chapter 2.2.46 are fulfilled, keeping the ratios of concentrations between all solutions as described.<\/p>\n<p>Solution A: dilute hydrochloric acid R1 or a sample preparation buffer suitable for the apparatus used.<\/p>\n<p>Test solution: Dissolve 30.0 mg of the substance to be examined in solution A and dilute to 50.0 mL with solution A.<\/p>\n<p>Reference solution (a): Dilute 1.0 mL of the test solution to 100.0 mL with solution A. Dilute 2.0 mL of this solution to 10.0 mL with solution A.<\/p>\n<p>Reference solution (b): Dissolve 30.0 mg of proline R in solution A and dilute to 100.0 mL with solution A. Dilute 1.0 mL of the solution to 250.0 mL with solution A.<\/p>\n<p>Reference solution (c): Dilute 6.0 mL of ammonium standard solution (100 ppm NH<sub>4<\/sub>) R to 50.0 mL with solution A. Dilute 1.0 mL of this solution to 100.0 mL with solution A.<\/p>\n<p>Reference solution (d): Dissolve 30 mg of isoleucine R and 30 mg of leucine R in solution A and dilute to 50.0 mL with solution A. Dilute 1.0 mL of the solution to 200.0 mL with solution A.<\/p>\n<p>Blank solution: Solution A.<\/p>\n<p>Inject suitable, equal amounts of the test, blank and reference solutions into the amino acid analyser. Run a program suitable for the determination of physiological amino acids.<\/p>\n<p>System suitability: Reference solution (d):<\/p>\n<p>\u2014 resolution: minimum 1.5 between the peaks due to isoleucine and leucine.<\/p>\n<p>Calculation of percentage contents:<\/p>\n<p>\u2014 for any ninhydrin-positive substance detected at 570 nm, use the concentration of serine in reference solution (a);<\/p>\n<p>\u2014 for any ninhydrin-positive substance detected at 440 nm, use the concentration of proline in reference solution (b); if a peak is above the reporting threshold at both wavelengths, use the result obtained at 570 nm for quantification.<\/p>\n<p>Limits:<\/p>\n<p>\u2014 any ninhydrin-positive substance: for each impurity, maximum 0.2 per cent;<\/p>\n<p>\u2014 total: maximum 0.5 per cent;<\/p>\n<p>\u2014 reporting threshold: 0.05 per cent.<\/p>\n<p>The thresholds indicated under Related substances (Table 2034.-1) in the general monograph Substances for pharmaceutical use (2034) do not apply.<\/p>\n<h3>Chlorides (2.4.4)<\/h3>\n<p>Maximum 200 ppm.<\/p>\n<p>Dilute 5 mL of solution S to 15 mL with water R.<\/p>\n<h3>Sulfates (2.4.13)<\/h3>\n<p>Maximum 300 ppm.<\/p>\n<p>Dilute 10 mL of solution S to 15 mL with distilled water R.<\/p>\n<h3>Ammonium<\/h3>\n<p>Amino acid analysis (2.2.56) as described in the test for ninhydrin-positive substances with the following modifications.<\/p>\n<p>Injection: Test solution, reference solution (c) and blank solution.<\/p>\n<p>Limit:<\/p>\n<p>\u2014 ammonium at 570 nm: not more than the area of the corresponding peak in the chromatogram obtained with reference solution (c) (0.02 per cent), taking into account the peak due to ammonium in the chromatogram obtained with the blank solution.<\/p>\n<h3>Iron (2.4.9)<\/h3>\n<p>Maximum 10 ppm.<\/p>\n<p>In a separating funnel, dissolve 1.0 g in 10 mL of dilute hydrochloric acid R. Shake with 3 quantities, each of 10 mL, of methyl isobutyl ketone R1, shaking for 3 min each time. To the combined organic layers add 10 mL of water R and shake for 3 min. Use the aqueous layer.<\/p>\n<h4>Loss on drying (2.2.32)<\/h4>\n<p>Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105\u00b0C.<\/p>\n<h4>Sulfated ash (2.4.14)<\/h4>\n<p>Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n<h2>ASSAY<\/h2>\n<p>Dissolve 0.100 g in 3 mL of anhydrous formic acid R. Add 30 mL of anhydrous acetic acid R. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20).<\/p>\n<p>1 mL of 0.1 M perchloric acid is equivalent to 10.51 mg of C<sub>3<\/sub>H<sub>7<\/sub>NO<sub>3<\/sub>.<\/p>\n<h2>STORAGE<\/h2>\n<p>Protected from light.<\/p>\n<h2>IMPURITIES<\/h2>\n<p>Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other\/unspecified impurities. It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use) A, B, C.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29343\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-2-300x163.jpg\" alt=\"Serine\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-2-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-2-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-2-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-2.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>A. (2S)-2-aminopropanoic acid (alanine),<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29344\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-3-300x163.jpg\" alt=\"Serine\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-3-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-3-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-3-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-3.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>B. 2-aminoacetic acid (glycine),<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29345\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-4-300x163.jpg\" alt=\"Serine\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-4-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-4-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-4-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/Serine-4.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>C. (2S)-2-amino-3-(imidazol-4-yl)propanoic acid (histidine).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Ph. Eur. monograph 0788) C3H7NO3\u00a0 \u00a0 \u00a0 \u00a0 105.1\u00a0 \u00a0 \u00a0 \u00a0 \u00a056-45-1 Action and use Amino acid. DEFINITION (2S)-2-Amino-3-hydroxypropanoic acid. Product of fermentation or of protein hydrolysis. Content 98.5 per cent to 101.0 per cent (dried substance). CHARACTERS Appearance White or almost white, crystalline powder or colourless crystals. Solubility Freely soluble in water, practically&#8230;<\/p>\n","protected":false},"author":2,"featured_media":29346,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-29329","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=29329"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29329\/revisions"}],"predecessor-version":[{"id":29356,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29329\/revisions\/29356"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/29346"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=29329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=29329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=29329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}